ReviewBMC pediatrics2026
Platelet-rich fibrin therapy for skin necrosis caused by intravenous extravasation of arginine hydrochloride: a case report and literature review.
Review in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArginine hydrochloride, widely used in growth hormone stimulation tests, can cause local swelling and, rarely, full-thickness skin necrosis, usually managed conservatively or with skin grafting. Platelet-rich fibrin (PRF) but its use in arginine hydrochloride–induced necrosis has not been reported. This study presents a pediatric case treated with PRF. CASE PRESENTATION: A 6.6-year-old girl with short stature underwent a growth hormone stimulation test. During peripheral intravenous infusion of arginine hydrochloride (9.1 g diluted in 10% sterile water at 180 mL/h), extravasation was detected 30 minutes after initiation. Initial management included prompt discontinuation of the infusion, limb elevation, and local dressing care; however, necrotic bullae developed. Despite debridement, topical sulfonated polyglycosaminoglycan, and red-light therapy, a deep ulcer formed on the dorsum of the left hand, extending to the muscle layer. On day 24, surgical debridement with preservation of tendon structures and autologous dermal grafting harvested from the scalp was performed. On day 32, allogeneic PRF prepared from 20 mL of maternal blood and supplemented with acidic fibroblast growth factor was applied to the exposed tendons. Postoperatively, the patient underwent regular outpatient follow-up with wound assessment, scar management, and hand function rehabilitation. At the 129-day follow-up, the wound had healed with a mildly raised scar, hand function was preserved, and the cosmetic outcome was satisfactory.
conclusionExtravasation of arginine hydrochloride may cause severe skin necrosis in children; early recognition and multidisciplinary management, including surgery and PRF therapy, can improve healing and functional and cosmetic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.